206 related articles for article (PubMed ID: 21311098)
21. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
22. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
[TBL] [Abstract][Full Text] [Related]
24. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
25. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
[TBL] [Abstract][Full Text] [Related]
26. 14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells.
Macha MA; Matta A; Chauhan S; Siu KM; Ralhan R
BMC Cancer; 2010 Nov; 10():655. PubMed ID: 21118500
[TBL] [Abstract][Full Text] [Related]
27. Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma.
Ota I; Ohnishi K; Takahashi A; Yane K; Kanata H; Miyahara H; Ohnishi T; Hosoi H
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):495-501. PubMed ID: 10802378
[TBL] [Abstract][Full Text] [Related]
28. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
[TBL] [Abstract][Full Text] [Related]
29. Ninein-like protein is overexpressed in head and neck squamous cell carcinoma and contributes to cancer growth and resistance to apoptosis.
Yu L; Song Y; Zhang Q; Zhan Q
Oncol Rep; 2009 Oct; 22(4):789-98. PubMed ID: 19724857
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
31. Validation of gefitinib effectiveness in a broad panel of head and neck squamous carcinoma cells.
Sebastian S; Azzariti A; Accardi R; Conti D; Pilato B; LaCalamita R; Porcelli L; Simone GM; Tommasi S; Tommasino M; Paradiso A
Int J Mol Med; 2008 Jun; 21(6):809-17. PubMed ID: 18506376
[TBL] [Abstract][Full Text] [Related]
32. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
[TBL] [Abstract][Full Text] [Related]
33. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
34. Nod-like receptors in head and neck squamous cell carcinoma.
Millrud CR; Kvarnhammar AM; Tajti J; Munck-Wikland E; Uddman R; Cardell LO
Acta Otolaryngol; 2013 Dec; 133(12):1333-44. PubMed ID: 24053487
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitin-conjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer.
Maeda H; Miyajima N; Kano S; Tsukiyama T; Okumura F; Fukuda S; Hatakeyama S
Mol Cancer Res; 2009 Sep; 7(9):1553-62. PubMed ID: 19723876
[TBL] [Abstract][Full Text] [Related]
36. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
37. AIS is an oncogene amplified in squamous cell carcinoma.
Hibi K; Trink B; Patturajan M; Westra WH; Caballero OL; Hill DE; Ratovitski EA; Jen J; Sidransky D
Proc Natl Acad Sci U S A; 2000 May; 97(10):5462-7. PubMed ID: 10805802
[TBL] [Abstract][Full Text] [Related]
38. Targeting HOTAIR Induces Mitochondria Related Apoptosis and Inhibits Tumor Growth in Head and Neck Squamous Cell Carcinoma in vitro and in vivo.
Kong L; Zhou X; Wu Y; Wang Y; Chen L; Li P; Liu S; Sun S; Ren Y; Mei M; Wang X; Zhang L
Curr Mol Med; 2015; 15(10):952-60. PubMed ID: 26592246
[TBL] [Abstract][Full Text] [Related]
39. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells.
Zhang X; Huang Z; Hu Y; Liu L
J Oral Pathol Med; 2016 Nov; 45(10):740-745. PubMed ID: 27561828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
